Agreements reached under this partnership
Business Alliance- 1
Preparations will proceed for an arrangement under which the Company supplies the products and TAUNS Laboratories,Inc. is responsible for sales in the domestic clinic market.
- 2
The relevant products comprise 3 items, including the in vitro diagnostic medical products “ImmunoCatch® Adeno” and “ImmunoCatch® Strep A,” manufactured and marketed by the Company.
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
This matter is reflected in the Company's consolidated earnings forecast for the current fiscal year.
| Item | Details |
|---|---|
| Name of alliance partner | TAUNS Laboratories,Inc. |
| Alliance partner's business activities | TAUNS Laboratories,Inc. has an extensive sales platform in the infectious disease diagnostics field. |
| Alliance partner's location | Izunokuni, Shizuoka Prefecture |
| Type of alliance | Business Alliance |
| Details of the alliance | Preparations will proceed for an arrangement under which the Company supplies the products and TAUNS Laboratories,Inc. is responsible for sales in the domestic clinic market., The relevant products comprise 3 items, including the in vitro diagnostic medical products “ImmunoCatch® Adeno” and “ImmunoCatch® Strep A,” manufactured and marketed by the Company. |
| Alliance start date | Aiming to begin sales this autumn |
| Impact on Business Performance | This matter is reflected in the Company's consolidated earnings forecast for the current fiscal year. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen the deployment of POCT products in the clinic market by enhancing the profitability of the domestic business and responding to growing demand for rapid diagnostics. By combining TAUNS Laboratories,Inc.'s sales platform in the infectious disease diagnostics field with the Company's product quality and development capabilities, the companies expect to expand the adoption of the relevant products.